Humana is making a contrarian Medicare Advantage land-grab—betting its CenterWell “payvidor” engine and Star Ratings recovery can turn a 2026 earnings trough into a 2028–2031 margin super-cycle.
Overview
Humana is a leading U.S. managed care company and the #2 Medicare Advantage insurer, positioned at the center of the “silver tsunami” as Medicare enrollment expands. The company derives ~83% of revenue from federal programs and operates through two pillars: (1) Insurance, covering ~15M medical members and ~4.7M specialty members with Medicare Advantage as the crown jewel, and (2) CenterWell, its vertically integrated care delivery platform (senior primary care, home health, pharmacy) that underpins the “payvidor” model. In 2026, Humana made a bold strategic choice to expand MA membership aggressively while competitors (UNH, Aetna/CVS) pulled back to recover margins—driving ~1.2M membership growth early in the year and potentially setting Humana up to become the largest MA insurer. Customer acquisition and retention are central: in a crowded plan market, Humana emphasizes simplified benefit design, service quality, and better clinical outcomes, which translated into improved AEP retention and satisfaction. The near-term setup is a classic volume-vs-margin trade: rapid growth boosts revenue but pressures earnings until cohorts mature, Star Ratings stabilize, and the integrated CenterWell model delivers cost control.